Innate Pharma IPHA
NASDAQ IPHA
$1.59 +0.05 (+3.25%)
As of: Nov 11, 2026 · 3:56 PM EST

Innate Pharma (IPHA) Ending Cash Balance (2017 - 2026)

Updated

Analysis

Innate Pharma (IPHA) Ending Cash Balance (2017 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Ending Cash Balance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 4.89 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 16.91 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 10.77 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 9.65 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 7.94 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 13.19 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 6.44 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 1.88 Bn
10 Innate Pharma 142.45 Mn -64.74 Mn - 7.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.38 Mn
Dec 31, 2025 33.00 Mn
Jun 30, 2025 62.98 Mn
Dec 31, 2024 69.09 Mn
Jun 30, 2024 74.95 Mn
Dec 31, 2023 78.15 Mn
Jun 30, 2023 77.61 Mn
Dec 31, 2022 89.79 Mn
Jun 30, 2022 107.55 Mn
Dec 31, 2021 117.50 Mn
Jun 30, 2021 123.76 Mn
Dec 31, 2020 168.25 Mn
Jun 30, 2020 147.95 Mn
Dec 31, 2019 227.28 Mn
Jun 30, 2019 169.88 Mn
Dec 31, 2018 174.25 Mn
Dec 31, 2017 118.66 Mn
API Access

Innate Pharma Ending Cash Balance API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=IPHA&period=max&api_key=YOUR_API_KEY